
Photo: NDTV Profit
Business & Finance
FDA Adds Warning Label To Obesity Drugs For Eye Condition
TL;DR
- The US Food and Drug Administration will now require GLP-1 drugs including Novo's Wegovy and Ozempic and Lilly's Mounjaro, Zepbound and Foundayo to carry warnings that they may increase the risk of non-arteritic anterior ischemic optic neuropathy, or NAION.
Short summary
Our full write-up is on its way. For the complete story, read the original report:
Nov 9, 2026 · Updated 11/9/2026, 6:34:08 PM · Reported with: NDTV Profit
Sources (1)
NRI Bytes writes its own articles from the reporting below.
NDTV Profit — FDA Adds Warning Label To Obesity Drugs For Eye ConditionUp next · Business & Finance
Pakistani man sentenced to 27 years in US prison for plot to assassinate Trump and other politicians
Read next →
More stories
Business & Finance
Samsung Heavy Industries eyes India for shipbuilding
37m ago

Business & Finance
Balancing AI-driven estimates and ground-level evidence in official statistics
37m ago
Business & Finance
Global Market Today: Asian shares rebound as Nvidia forecast eases AI trade concerns
54m ago
Business & Finance
Industry bodies look for tax sops, benefits to boost mananufacturing
1h ago

